Protagonist Therapeutics Stock Price Prediction
| PTGX Stock | USD 25.57 0.54 2.07% |
Oversold Vs Overbought
46
Oversold | Overbought |
Protagonist Therapeutics stock price prediction is an act of determining the future value of Protagonist Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Protagonist Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Protagonist Therapeutics and does not consider all of the tangible or intangible factors available from Protagonist Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Protagonist Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Protagonist Therapeutics' stock price prediction:EPS Estimate Next Quarter 0.67 | EPS Estimate Current Year 0.75 | EPS Estimate Next Year (0.81) | Wall Street Target Price 44.2 | EPS Estimate Current Quarter (0.03) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Protagonist Therapeutics based on different types of headlines from major news networks to social media. The Protagonist stock price prediction module provides an analysis of price elasticity to changes in media outlook on Protagonist Therapeutics over a specific investment horizon. Using Protagonist Therapeutics hype-based prediction, you can estimate the value of Protagonist Therapeutics from the perspective of Protagonist Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Protagonist Therapeutics using Protagonist Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Protagonist using crowd psychology based on the activity and movement of Protagonist Therapeutics' stock price.
Protagonist Therapeutics Short Interest
A significant increase or decrease in Protagonist Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Protagonist. Short interest can provide insight into the potential direction of Protagonist Therapeutics stock and how bullish or bearish investors feel about the market overall. An investor who is long Protagonist Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Protagonist Therapeutics and may potentially protect profits, hedge Protagonist Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 21.7307 | Short Percent 0.0597 | Short Ratio 5.47 | Shares Short Prior Month 3.4 M | 50 Day MA 28.4598 |
Protagonist Therapeutics Hype to Price Pattern
Investor biases related to Protagonist Therapeutics' public news can be used to forecast risks associated with an investment in Protagonist. The trend in average sentiment can be used to explain how an investor holding Protagonist can time the market purely based on public headlines and social activities around Protagonist Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Protagonist Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Protagonist Therapeutics.
Protagonist Therapeutics Implied Volatility | 80.61 |
Protagonist Therapeutics' implied volatility exposes the market's sentiment of Protagonist Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Protagonist Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Protagonist Therapeutics stock will not fluctuate a lot when Protagonist Therapeutics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Protagonist Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Protagonist Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Protagonist because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Protagonist Therapeutics after-hype prediction price | USD 26.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Protagonist |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Protagonist Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Protagonist Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Protagonist Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Protagonist Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Protagonist Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Protagonist Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Protagonist Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Protagonist Therapeutics' historical news coverage. Protagonist Therapeutics' after-hype downside and upside margins for the prediction period are 22.84 and 29.24, respectively. We have considered Protagonist Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Protagonist Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Protagonist Therapeutics is based on 3 months time horizon.
Protagonist Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Protagonist Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Protagonist Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Protagonist Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.19 | 3.20 | 0.07 | 0.05 | 9 Events / Month | 16 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
25.57 | 26.04 | 0.27 |
|
Protagonist Therapeutics Hype Timeline
Protagonist Therapeutics is at this time traded for 25.57. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of -0.05. Protagonist is forecasted to decline in value after the next headline, with the price expected to drop to 26.04. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.27%, whereas the daily expected return is at this time at 0.19%. The volatility of related hype on Protagonist Therapeutics is about 1322.83%, with the expected price after the next announcement by competition of 25.52. About 98.0% of the company shares are owned by institutional investors. The book value of Protagonist Therapeutics was at this time reported as 5.83. The company recorded a loss per share of 1.39. Protagonist Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out Protagonist Therapeutics Basic Forecasting Models to cross-verify your projections.Protagonist Therapeutics Related Hype Analysis
Having access to credible news sources related to Protagonist Therapeutics' direct competition is more important than ever and may enhance your ability to predict Protagonist Therapeutics' future price movements. Getting to know how Protagonist Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Protagonist Therapeutics may potentially react to the hype associated with one of its peers.
Protagonist Therapeutics Additional Predictive Modules
Most predictive techniques to examine Protagonist price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Protagonist using various technical indicators. When you analyze Protagonist charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Protagonist Therapeutics Predictive Indicators
The successful prediction of Protagonist Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Protagonist Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Protagonist Therapeutics based on analysis of Protagonist Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Protagonist Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Protagonist Therapeutics's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 7.74 | 7.61 | 16.71 | 17.55 | Net Debt To EBITDA | 0.94 | 0.93 | 2.05 | 1.03 |
Story Coverage note for Protagonist Therapeutics
The number of cover stories for Protagonist Therapeutics depends on current market conditions and Protagonist Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Protagonist Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Protagonist Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Protagonist Therapeutics Short Properties
Protagonist Therapeutics' future price predictability will typically decrease when Protagonist Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Protagonist Therapeutics often depends not only on the future outlook of the potential Protagonist Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Protagonist Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 56.8 M | |
| Cash And Short Term Investments | 341.6 M |
Check out Protagonist Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.Note that the Protagonist Therapeutics information on this page should be used as a complementary analysis to other Protagonist Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Protagonist Stock analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Protagonist Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protagonist Therapeutics. If investors know Protagonist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protagonist Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 1.057 | Quarterly Revenue Growth (1.00) | Return On Assets (0.19) | Return On Equity (0.29) |
The market value of Protagonist Therapeutics is measured differently than its book value, which is the value of Protagonist that is recorded on the company's balance sheet. Investors also form their own opinion of Protagonist Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protagonist Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protagonist Therapeutics' market value can be influenced by many factors that don't directly affect Protagonist Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protagonist Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protagonist Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protagonist Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.